Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, R. B.
Right arrow Articles by MD, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, R. B.
Right arrow Articles by MD, P. G.
NEUROLOGY 1992;42:1859
© 1992 American Academy of Neurology

Analysis of the prion protein gene in thalamic dementia

R. B. Petersen, PhD, M. Tabaton MD, L. Berg MD, B. Schrank MD, R. M. Torack, MD, S. Leal MS, J. Julien MD, C. Vital MD, B. Deleplanque MD, W. W. Pendlebury, MD, D. Drachman MD, T. W. Smith, MD, J. J. Martin, MD, M. Oda MD, P. Montagna MD, J. Ott PhD, L. Autilio-Gambetti PhD, E. Lugaresi MD and P. Gambetti MD

Division of Neuropathology (Drs. Petersen, Tabaton, Autilio-Gambetti, and Gambetti), Institute of Pathology, Case Western Reserve University, Cleveland, OH; the Departments of Neurology (Dr. Berg), Genetics (Dr. Schrank), and Pathology (Dr. Torack), Washington University School of Medicine, St. Louis, MO; the Department of Genetics and Development (S. Leal and Dr. Ott), Columbia University, New York, Ny; the Departments of Neurology (Drs. Julien and Deleplanque) and Pathology (Dr. Vital), University of Bordeaux Medical School, Bordeaux, France; the Department of Pathology (Dr. Pendlebury), University of Vermont, Burlington, VT; the Department of Neurology (Drs. Drachman and Smith), University of Massachusetts, Worcester, MA, the Laboratory of Neuropathology (Dr. Martin), Universitaire Instelling Antwerpen, Wilrijk, Belgium; the Division of Pathology (Dr. Oda), Tokyo Metropolitan Neurological Hospital, Tokyo, Japan; and the Neurological Institute (Drs. Montagna and Lugaresi), University of Bologna, Bologna, Italy.

Thalamic degenerations or dementias are poorly understood conditions. The familial forms are (1) selective thalamic degenerations and (2) thalamic degenerations associated with multiple system atrophy. Selective thalamic degenerations share clinical and pathologic features with fatal familial insomnia, an autosomal dominant disease linked to a mutation at codon 178 of the prion protein (PrP) gene that causes the substitution of asparagine for aspartic acid (178Asn mutation). We amplified the carboxyl terminal coding region of the PrP gene from subjects with selective thalamic dementia or thalamic dementia associated with multiple system atrophy. Three of the four kindreds with selective thalamic dementia and none of the three kindreds with thalamic dementia associated with multiple system atrophy had the PrP 178Asn mutation. Thus, analysis of the PrP gene may be useful in diagnosing the subtypes of thalamic dementia. Moreover, since selective thalamic dementia with the PrP 178Asn mutation and fatal familial insomnia share clinical and histopathologic features, we propose that they are the same disease.

Address correspondence and reprint requests to Dr. Robert B. Petersen, Division of Neuropathology, Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106.

Supported by NINCDS NS 14509–13, NIA ADRC AG–08012–02, NIH NIA 1 R01 AGNS08155-Q, the Britton Fund, and NIH HG 0008 (J.O.).

Received May 15, 1992. Accepted for publication in final form June 8, 1992.




This article has been cited by other articles:


Home page
Biophys. JHome page
G. Settanni, T. X. Hoang, C. Micheletti, and A. Maritan
Folding Pathways of Prion and Doppel
Biophys. J., December 1, 2002; 83(6): 3533 - 3541.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. B. Prusiner
Neurodegenerative Diseases and Prions
N. Engl. J. Med., May 17, 2001; 344(20): 1516 - 1526.
[Full Text] [PDF]


Home page
NEJMHome page
J. A. Mastrianni, R. Nixon, R. Layzer, G. C. Telling, D. Han, S. J. DeArmond, and S. B. Prusiner
Prion Protein Conformation in a Patient with Sporadic Fatal Insomnia
N. Engl. J. Med., May 27, 1999; 340(21): 1630 - 1638.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Prusiner
Prions
PNAS, November 10, 1998; 95(23): 13363 - 13383.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
I. Y. Lee, D. Westaway, A. F.A. Smit, K. Wang, J. Seto, L. Chen, C. Acharya, M. Ankener, D. Baskin, C. Cooper, et al.
Complete Genomic Sequence and Analysis of the Prion Protein Gene Region from Three Mammalian Species
Genome Res., October 1, 1998; 8(10): 1022 - 1037.
[Abstract] [Full Text]


Home page
ScienceHome page
S. B. Prusiner
Prion Diseases and the BSE Crisis
Science, October 10, 1997; 278(5336): 245 - 251.
[Abstract] [Full Text]


Home page
ScienceHome page
G. C. Telling, P. Parchi, S. J. DeArmond, P. Cortelli, P. Montagna, R. Gabizon, J. Mastrianni, E. Lugaresi, P. Gambetti, and S. B. Prusiner
Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity
Science, December 20, 1996; 274(5295): 2079 - 2082.
[Abstract] [Full Text]


Home page
Cold Spring Harb Symp Quant BiolHome page
S.B. Prusiner
Molecular Biology and Genetics of Prion Diseases
Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 473 - 493.
[Abstract] [PDF]


Home page
ScienceHome page
F. Cohen, K. Pan, Z Huang, M Baldwin, R. Fletterick, and S. Prusiner
Structural clues to prion replication
Science, April 22, 1994; 264(5158): 530 - 531.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by AAN Enterprises, Inc.